semaglutide liver targets MASH molecular pathways beyond weight loss Ozempic Can Treat Fatty Liver

166 Gp78 binds to the C-terminal region of the nonglycosylated prion protein PrP, which is implicated in bovine spongiform encephalopathy and CreutzfeltdJacob disease, promoting PrP degradation

An overview of COVID-19 in people with diabetes: pathophysiology and considerations in the inpatient setting

2024;16(16) doi: 10.3390/nu16162809

Mazdutide (IBI362), developed by Innovent Biologics with Eli Lilly China, is an oxyntomodulin analog that has progressed through seven Phase 3 trials and gained regulatory approval in China for type 2 diabetes

New experimental results have been incorporated to complete and strengthen the study, accompanied by two new figures illustrating these findings (Figure 2